Experimental Estimation of Immunomodulating Activity of Tubosan, a New Russian Synthetic Drug by N. K. Chernikova, V. V. Mikhailov, S. V. Borisevich

Subjects: Get full text

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) in Children 9–23 Months of Age in Russian Federation: Results of Russian Part of Internation... by O. A. Perminova, V. V. Romanenko, V. Yu. Rodnikova, S. M. Kharit, Y. Thollot, V. Bosch-Castells, A. V. Goldstein

Subjects: Get full text

Evaluation of Vaccine Strategies among Healthcare Workers during COVID-19 Omicron Outbreak in Taiwan by Min-Ru Lin, Chung-Guei Huang, Cheng-Hsun Chiu, Chih-Jung Chen

Subjects: Get full text

Safety and immunological effectiveness of the domestic combined trivaccine for the prevention of measles, rubella and mumps Vaktrivir^® in children 12 months and 6 years... by I. V. Feldblium, V. V. Romanenko, K. A. Subbotina, M. G. Menshikova, I. A. Okuneva, A. Y. Musikhina, T. E. Snitkovskaya, N. I. Marcovich, A. E. Ershov, D. M. Trofimov

Subjects: Get full text

Diminishing reactogenicity with preserved immunogenicity in COVID-19 vaccines: A longitudinal observation from primary to updated booster vaccine cohorts by Hyun Myung Kang, Ho Jun Lee, Jin Yang Baek, Hye-Jin Kim, Young Jae Lee, Ju-Yeon Choi, Hye-Sook Jeong, Eui Ho Kim, Kyong Ran Peck, Jae-Hoon Ko

Subjects: Get full text

Safety and immunogenicity of a bivalent norovirus vaccine candidate in infants from 6 weeks to 5 months of age: A phase 2, randomized, double-blind trial by Xavier Sáez-Llorens, Rodrigo deAntonio, Eduardo López-Medina, Pío López, Taisei Masuda, Paul M Mendelman, Jim Sherwood, Frank Baehner, Astrid Borkowski

Subjects: Get full text

VACCINATION OF PREMATURE/LOW-BIRTH-WEIGHT CHILDREN by V. K. Tatochenko

Subjects: Get full text

Innovative micro physiological systems for vaccine development by Kendra Reynaud, Scott Atwell, Christophe Védrine, Cyril Guyard, Laurent Beloeil

Subjects: Get full text

Analysis of Efficacy and Safety of Tick-Borne Encephalitis Vaccines by T. Yu. Kozlova, L. M. Khantimirova, A. V. Rukavishnikov, V. A. Shevtsov

Subjects: Get full text

An mRNA-based seasonal influenza vaccine in adults: Results of two phase 3 randomized clinical trials and correlate of protection analysis of hemagglutination inhibition titers by Boris Kandinov, Mieke Soens, Wenmei Huang, Conrado Llapur, David Ensz, Brandon Essink, Carlos Fierro, Jignesh Vakil, Alicia Pucci, Jia Guo, Sinead Rudden, Kristi Hall, Bryony Hicks, Kristin Schaefers, Honghong Zhou, Chong Ma, Lingyi Zheng, Andrei Avanesov, Yoonyoung Park, Evelyn Du, Jacqueline Miller, Jintanat Ananworanich, Raffael Nachbagauer

Subjects: Get full text

Efficacy, reactogenicity, and safety of the adjuvanted recombinant zoster vaccine for the prevention of herpes zoster in Chinese adults ≥ 50 years: A randomized, placebo-controlled... by Diana Alexandra Echeverria Proano, Fengcai Zhu, Xiaodong Sun, Jesús Zoco, Jyoti Soni, Neeraj Parmar, S. Omar Ali

Subjects: Get full text

Less reactogenic whole-cell pertussis vaccine confers protection from Bordetella pertussis infection by Karolína Škopová, Jana Holubová, Barbora Bočková, Eva Slivenecká, João Melo Santos de Barros, Ondřej Staněk, Peter Šebo

Subjects: Get full text

Safety of Tetravalent Conjugate Meningococcal Vaccine (Serotypes A, C, Y, W) for 1–4 Years Old Children With Distresses and Chronic Diseases in Closed Healthcare Facility: Cohort S... by Alebai U. Sabitov, Mariya V. Frajfeld

Subjects: Get full text

COMBINED VACCINES IN PEDIATRIC PRACTICE: WHEN THE PERTUSSIS VACCINE IS FUN! by V. K. Tatochenko

Subjects: Get full text

Pneumococcal conjugate 7-valent vacciPNEUMOCOCCAL CONJUGATE 7-VALENT VACCINE IN CHILDREN. REGIONAL EXPERIENCEne in children. Regional experience by N. L. Chernaya, O. B. Dadayeva, V. M. Ganuzin, G. S. Ganuzina, S. E. Batorshina, I. V. Ivanova

Subjects: Get full text

Safety and Immunogenicity of Fully Liquid Hexavalent DTaP-IPV-HepB-Hib Vaccine in Healthy Infants in Russian Federation by L. S. Namazova-Baranova, S. M. Kharit, O. A. Perminova, V. V. Romanenko, I. V. Osipova, А. G. Asatryan, A. V. Goldstein, S. B'Chir, O. I. Lyabis

Subjects: Get full text

Pre-Vaccination Immune Profiles and Responsiveness to Innate Stimuli Predict Reactogenicity and Antibody Magnitude Following mRNA Vaccination by Amanda E. Zelkoski, Emilie Goguet, Emily Samuels Darcey, Mohamad-Gabriel Alameh, Hooda Said, Simon Pollett, John H. Powers, Eric D. Laing, Cara Olsen, Edward Mitre, Allison M. W. Malloy

Subjects: Get full text

Safety profile of self-amplifying mRNA SARS-CoV-2 vaccine ARCT-154 in adults: a pooled phase 1/2/3 randomized clinical study by Nhan Thi Ho, Igor Smolenov, Ly Thi Le Tran, Van Thu Nguyen, Van Thanh Ta, Thuong Vu Nguyen, Hung Ngoc Pham, Anh Thi Van Pham, Quang Chan Luong, Men Van Chu, Mai Thi Ngoc Dang, Toan Trong Nguyen, Vy Thi Tuong Le, Quang Vinh Trinh, Thang Van Nguyen, Anh Ngoc Nguyen, Ha Thai Pham, Giang Duc Dao, Carmen Baccarini, Ekpeno Nnah, Alia Hawkes, Suezanne Parker, Carole Verhoeven, Judd L Walson, Xuan-Hung Nguyen

Subjects: Get full text

Safety Analysis for Pentavaccine Used in Premature Infants: Family Vaccination Centre’s Experiment by D. А. Novikova, L. S. Namazova-Baranova, А. G. Gayvoronskaya, М. I. Broeva, М. V. Fedoseenko

Subjects: Get full text

Clinical trial of tolerability, safety, and immunogenicity of the Russian influenza inactivated split vaccine Flu-m in children from 6 months to 9 years of age by A. M. Korolyuk, L. A. Zazimko, V. N. Kraeva, Yu. A. Koromzin, E. A. Ruzanova, A. A. Ekimov, N. N. Savina, E. V. Ryskova, V. P. Trukhin

Subjects: Get full text